Digital Interventions for Mild Cognitive Impairment
(MediDream Trial)
Trial Summary
What is the purpose of this trial?
The goal of this proposed research is to collect pilot data to test the hypothesis that treatment with a novel form of closed-loop digital meditation (MediTrain) will lead to a greater magnitude of gains in cognitive abilities in patients with mild cognitive impairment (MCI), compared to OA without cognitive impairment, and will lead to improvements in quantitative measures of sleep.
Will I have to stop taking my current medications?
You will need to stop taking anti-depressants and anti-anxiety medications to participate in this trial.
What data supports the effectiveness of the treatment MediTrain for mild cognitive impairment?
Research on similar digital interventions, like TECH and computer-based cognitive training, shows potential benefits in improving memory and cognitive functions in older adults with mild cognitive impairment. These studies suggest that digital treatments can help maintain or enhance cognitive abilities over time.12345
Is the digital intervention for mild cognitive impairment safe for humans?
How is the MediTrain treatment different from other treatments for mild cognitive impairment?
MediTrain is unique because it is a digital intervention specifically designed to address cognitive deficits in mild cognitive impairment (MCI) through interactive and engaging methods, unlike traditional treatments that may not focus on digital engagement. This approach leverages technology to provide cognitive training in a way that is accessible and potentially more engaging for patients.1241112
Research Team
David Ziegler, PhD
Principal Investigator
University of California, San Francisco
Eligibility Criteria
This trial is for older adults who are experiencing mild cognitive impairment. Participants should be interested in testing digital interventions aimed at improving cognition, wellbeing, stress levels, and sleep quality.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo treatment with a novel form of closed-loop digital meditation (MediTrain) to improve cognitive abilities and sleep quality
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at immediate and 6-month follow-up
Treatment Details
Interventions
- MediTrain (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
National Institute on Aging (NIA)
Collaborator